Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 519.50
-4.55 (-0.87%)
At close: Aug 17, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 55.19 billion as of August 17, 2026. Its market cap has increased by 209.66% in one year.
Market Cap
55.19B
Enterprise Value
53.91B
Revenue
10.05B
Ranking
n/a
PE Ratio
41.16
Stock Price
519.50
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 55.19B, an increase of 548,985.54%. That is a compound annual growth rate of 41.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 55.19B | 219.10% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 111.56B |
| Procter & Gamble Health | 98.50B |
| Sanofi India | 74.77B |
| FDC Limited | 57.68B |
| Morepen Laboratories | 46.15B |
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |